{"id":"https://openalex.org/W4361950757","doi":"https://doi.org/10.1158/1078-0432.c.6521484.v1","title":"Data from CD62L as a Therapeutic Target in Chronic Lymphocytic Leukemia","display_name":"Data from CD62L as a Therapeutic Target in Chronic Lymphocytic Leukemia","alternate_titles":[],"publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361950757","doi":"https://doi.org/10.1158/1078-0432.c.6521484.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6521484.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521484.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521484.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4361950757"],"child_works_count":0,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6521484.v1","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113802692","display_name":"Melinda Lea Burgess","orcid":"https://orcid.org/0009-0004-7520-0311","observed_orcids":["https://orcid.org/0009-0004-7520-0311"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melinda Burgess","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027054405","display_name":"Devinder Singh Gill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Devinder Gill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062874036","display_name":"Richa Singhania","orcid":"https://orcid.org/0000-0003-4449-0980","observed_orcids":["https://orcid.org/0000-0003-4449-0980","https://orcid.org/0009-0007-8684-3672"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richa Singhania","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111386033","display_name":"Catherine Wing Ying Cheung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine Cheung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Lynne Chambers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lynne Chambers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079549039","display_name":"Brent A. Renyolds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brent A. Renyolds","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111953573","display_name":"Louise Smith","orcid":"https://orcid.org/0000-0002-3213-4770","observed_orcids":["https://orcid.org/0000-0002-3213-4770"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Louise Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084858618","display_name":"Peter N. Mollee","orcid":"https://orcid.org/0000-0002-8537-1198","observed_orcids":["https://orcid.org/0000-0002-8537-1198"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Mollee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089011216","display_name":"Nicholas Andrew Saunders","orcid":"https://orcid.org/0000-0002-2478-3420","observed_orcids":["https://orcid.org/0000-0002-2478-3420"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicholas Saunders","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5073169676","display_name":"Nigel A.J. McMillan","orcid":"https://orcid.org/0000-0002-9471-1406","observed_orcids":["https://orcid.org/0000-0002-9471-1406"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nigel AJ McMillan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/l-selectin","display_name":"L-selectin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6869999766349792},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.6629999876022339},{"id":"https://openalex.org/keywords/cll-cell-survival","display_name":"CLL cell survival","score":0.8629999756813049},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.7889999747276306},{"id":"https://openalex.org/keywords/mafosfamide","display_name":"mafosfamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.8820000290870667},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cell-homing","display_name":"cell homing","score":0.6079999804496765},{"id":"https://openalex.org/keywords/cell-surface-molecules","display_name":"cell surface molecules","score":0.4009999930858612}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7104411721229553},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6639213562011719},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.5767408013343811},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5473038554191589},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5038394331932068},{"id":"https://openalex.org/C159912055","wikidata":"https://www.wikidata.org/wiki/Q14885119","display_name":"CD38","level":4,"score":0.49874401092529297},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.44613367319107056},{"id":"https://openalex.org/C113067387","wikidata":"https://www.wikidata.org/wiki/Q14912836","display_name":"CD5","level":3,"score":0.4339859187602997},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.418806254863739},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3908163607120514},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3775460720062256},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3540748655796051},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.33631253242492676},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2954540252685547},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25030457973480225},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.21229839324951172},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15393218398094177},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.1501176357269287},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6521484.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521484.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521484.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6521484.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521484.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521484.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2130506867","https://openalex.org/W2261122747","https://openalex.org/W2998243301","https://openalex.org/W2890986246","https://openalex.org/W2017963311","https://openalex.org/W4313351649","https://openalex.org/W2552977334","https://openalex.org/W2001042875","https://openalex.org/W2587685130","https://openalex.org/W2046125843"],"abstract_inverted_index":{"Purpose:":[0],"Despite":[1],"advances":[2],"in":[3,30,41,69,86,89,122,139,174,206],"the":[4,11,31,42,172,189,196],"treatment":[5],"of":[6,25,34,46,52,99,124,146],"chronic":[7],"lymphocytic":[8],"leukemia":[9],"(CLL),":[10],"disease":[12],"remains":[13],"incurable":[14],"with":[15,114,150,171,181,224],"standard":[16,228],"therapies":[17],"and":[18,44,88,92,108,182,198],"relapse":[19],"is":[20,188],"inevitable.":[21],"A":[22],"growing":[23],"body":[24],"evidence":[26],"indicates":[27],"that":[28,194,212],"alterations":[29],"adhesion":[32],"properties":[33],"neoplastic":[35],"cells":[36,64,85,126,149,154,157,162],"play":[37],"a":[38,104,134],"pivotal":[39],"role":[40,98,136],"development":[43],"progression":[45],"CLL.":[47],"Experimental":[48],"Design:":[49],"The":[50,71,96,143],"expression":[51,81],"71":[53],"cell":[54,141,204],"surface":[55],"molecules":[56],"was":[57,77,101],"examined":[58,78,102],"on":[59,82],"CLL":[60,84,125,140,148,161,203,225],"peripheral":[61],"blood":[62],"mononuclear":[63],"(PBMCs)":[65],"over":[66],"3":[67],"weeks":[68],"culture.":[70],"most":[72],"highly":[73],"upregulated":[74],"marker,":[75,200],"CD62L,":[76,201],"further":[79],"for":[80,137],"CD5+/CD19+":[83],"vitro":[87,175],"lymph":[90],"node":[91],"bone":[93,151],"marrow":[94,152],"biopsies.":[95],"prosurvival":[97],"CD62L":[100,120,138,216],"using":[103],"functional":[105],"blocking":[106,195],"antibody":[107],"therapeutic":[109,213],"potential":[110],"evaluated":[111],"by":[112],"comparison":[113],"current":[115,227],"chemotherapy":[116,229],"agents.":[117],"Results:":[118],"Blocking":[119],"resulted":[121],"apoptosis":[123],"but":[127],"not":[128,159],"PBMCs":[129],"from":[130,163],"healthy":[131],"donors":[132],"suggesting":[133],"novel":[135],"survival.":[142],"beneficial":[144],"effect":[145,179],"coculturing":[147],"stromal":[153,184],"or":[155,169],"endothelial":[156],"does":[158],"protect":[160],"anti-CD62L\u2013related":[164],"toxicity.":[165],"Moreover,":[166],"combining":[167],"fludarabine":[168],"mafosfamide":[170],"anti-CD62L":[173],"produced":[176],"an":[177],"additive":[178],"both":[180],"without":[183],"cells.":[185],"Conclusion:":[186],"This":[187],"first":[190],"reported":[191],"data":[192,209],"showing":[193],"activation":[197],"homing":[199],"regulates":[202],"survival":[205],"vitro.":[207],"These":[208],"also":[210],"suggest":[211],"antibodies":[214],"against":[215],"may":[217],"provide":[218],"additional":[219],"clinical":[220],"benefit":[221],"to":[222],"patients":[223],"receiving":[226],"protocols.":[230],"Clin":[231],"Cancer":[232],"Res;":[233],"19(20);":[234],"5675\u201385.":[235],"\u00a92013":[236],"AACR.":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4361950757","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2023-04-05T00:00:00"}
